Application Note: Cellular Metabolism - A New Avenue in Drug Discovery
31 August 2018

Finding novel druggable targets for therapeutic intervention is a major priority in building a robust drug discovery pipeline. Now, with a better understanding of the critical role of metabolism in diseases, researchers are approaching target identification in a whole new way. Agilent’s cell analysis portfolio provides tools to investigate metabolic targets more effectively for a range of diseases, paving the way for cellular energy metabolism as a new avenue for drug discovery.